From "Go" to "Go Public" and Beyond
We breathed life into the life sciences industry. The 1970s saw not only the emergence of the biotech sector, but also the emergence of Mintz as a leading law firm to the life sciences industry. We grew our capabilities in unison with the expansion of legal and business challenges facing industry companies.
Today, almost 50 years later, we have more than 150 practitioners providing a full spectrum of industry-specific business and litigation representation.Share Awards
Recognized in Life Sciences, Healthcare, and Capital Markets: Debt & Equity - USA – Nationwide
LMG Life Sciences
5 attorneys in IP, Litigation and Transactions identified as Life Sciences Stars (2017)
Firm recommended nationally for Licensing & Collaboration and Venture Capital Transactions (2017)
Legal 500 United States
Recommended for Middle Market: M&A; Health Care: Life Sciences; and Health Care: Service Providers
Managing Intellectual Property
US Life Sciences Patent Practice included on “Top Patent Firms” list (2018)
9 attorneys named "IP Stars" (2018)
U.S. News and Best Lawyers®
National Tier 1 ranking for Biotechnology Law and Health Care Law, "Best Law Firms"
M&A Today Global Awards
"Law Firm of the Year (Biotechnology) – North America" (2014 − 2016)
Ranked as "Law firm of the Year (Biotechnology) – North America" in the Global Awards (2014 – 2017)
Ranked as "Law Firm of the Year (Biotechnology)" (2016 – 2017)
What Our Clients Are Saying
More than 150 attorneys and professionals across the firm's eight offices serve life sciences companies in the United States and internationally.